Three-dimensional morphological condylar and mandibular changes in a patient with juvenile idiopathic arthritis: interdisciplinary treatment
Submitted: 10 November 2013
Accepted: 17 April 2014
Published: 6 November 2014
Accepted: 17 April 2014
Abstract Views: 2270
PDF: 1251
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- F. Trotta, G. Valentini, Safety of anti-TNFa biological drugs , Reumatismo: Vol. 57 No. s4 (2005)
- Giuseppe D'Alessandro, Maria Rosaria Bianco, Spiridon Politis, Celestino Ferrandina, Giuseppe Rossi, Emanuele Altomare, Case report: AREB in a patient with rheumatoid arthritis treated with methotrexate and infliximab , Reumatismo: Vol. 58 No. 1 (2006)
- E. Filippucci, A. Farina, F. Salaffi, W. Grassi, Hidden bone erosions , Reumatismo: Vol. 55 No. 1 (2003)
- A. Hoxha, A. Ruffatti, P. Grypiotis, M. Podswiadek, C. Botsios, U. Fiocco, L. Punzi, S. Todesco, Antinuclear, anti-dsDNA and anti-ENA antibodies in patients affected with rheumatoid arthritis or ankylosing spondylitis during treatement with infliximab , Reumatismo: Vol. 58 No. 2 (2006)
- P. Caramaschi, S. Pieropan, A. Volpe, A. Carletto, L.M Bambara, D. Biasi, Sustained response to infliximab treatment in two cases of early rheumatoid arthritis that has been maintained after drug withdrawal , Reumatismo: Vol. 60 No. 3 (2008)
- M. Taraborelli, L. Andreoli, S. Archetti, M. Ferrari, R. Cattaneo, A. Tincani, Methylenetetrahydrofolate reductase polymorphisms in methotrexate treatment of rheumatoid arthritis patients. Review of the literature and personal experience , Reumatismo: Vol. 61 No. 2 (2009)
- M. Turiel, S. Sitia, L. Tomasoni, S. Cicala, F. Atzeni, L. Gianturco, M. Longhi, V. De Gennaro Colonna, P. Sarzi-Puttini, Cardiac involvement in rheumatoid arthritis , Reumatismo: Vol. 61 No. 4 (2009)
- V. Bruzzese, J. Pepe, Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab) , Reumatismo: Vol. 61 No. 4 (2009)
- S. Bellissimo, F. Iannone, A. Musio, M. Covelli, G. Lapadula, Association of systemic sclerosis and psoriatic arthritis: a case report , Reumatismo: Vol. 53 No. 3 (2001)
- M. Covelli, P. Sarzi-Puttini, F. Atzeni, P. Macchioni, Safety of rituximab in rheumatoid arthritis , Reumatismo: Vol. 62 No. 2 (2010)
<< < 28 29 30 31 32 33 34 35 36 37 > >>
You may also start an advanced similarity search for this article.